Skip to content
Clinical Trials – home

Borderline personality disorder Treatment

3 / 3 trials open to patients3 countries

In short

Borderline personality disorder (BPD) is a challenging mental health condition that profoundly affects emotions, relationships, and daily functioning. While the intense mood swings, fear of abandonment, and impulsive behaviors can feel overwhelming, treatment—particularly through specialized talk therapy—can bring meaningful relief and stability to those living with this condition.

Key points

  • Talk therapy, not medication, is the foundation of borderline personality disorder treatment, with Dialectical Behavior Therapy being the only approach with strong research support.
  • Many people with BPD naturally improve with age as mood swings, anger, and impulsiveness decrease, making recovery even more achievable with proper treatment.
  • Effective BPD treatment typically takes more than a year, allowing time to learn skills, practice them in real life, and create lasting behavioral changes.
  • DBT teaches four essential skill sets—mindfulness, interpersonal effectiveness, emotion regulation, and distress tolerance—that work together to help manage intense emotions.
  • People with BPD often describe feeling like they have an "exposed nerve ending," reacting intensely to situations others find only mildly upsetting—treatment helps create a protective buffer.
  • BPD is only diagnosed in adults because behaviors resembling BPD in children and teenagers often naturally disappear as young people mature.
  • Most people with borderline personality disorder have at least one other mental health condition, such as depression, anxiety, PTSD, or substance use problems, which also need treatment attention.
  • Treatment involves teamwork—patients work with therapists and group members while therapists collaborate as teams—requiring active participation rather than passive receiving of care.

How Treatment Helps People with Borderline Personality Disorder

The main goal of treating borderline personality disorder is to help individuals manage intense emotions, reduce impulsive behaviors, and build healthier relationships. Because BPD affects nearly every aspect of a person's life—from how they see themselves to how they connect with others—treatment needs to address these multiple layers of difficulty. People with this condition often describe feeling like they have an "exposed nerve ending," meaning they react intensely to situations that others might find only mildly upsetting. Treatment aims to create a buffer against this emotional vulnerability.

The severity and pattern of symptoms vary from person to person, and so does the treatment approach. Some individuals experience symptoms that interfere significantly with work, friendships, and family life, while others have milder episodes. Typically, borderline personality disorder begins to show up in early adulthood, and the condition tends to be most severe during young adulthood. Many people find that mood swings, anger, and impulsiveness gradually improve with age, though issues around self-image and relationship difficulties often persist without treatment.

Standard treatments focus on teaching skills to handle difficult emotions, helping people understand their patterns of thinking and behavior, and improving their ability to function day-to-day. Beyond approved therapies, researchers are also exploring new approaches through clinical trials, seeking better ways to help people with borderline personality disorder achieve lasting stability and satisfaction in their lives.

Approved Methods for Treating Borderline Personality Disorder

The cornerstone of borderline personality disorder treatment is psychotherapy, which is also called talk therapy. Unlike many other mental health conditions, medication is not the primary treatment for BPD. Instead, structured psychological therapies form the foundation of care, with medication sometimes added to address specific symptoms or co-occurring conditions.

Dialectical Behavior Therapy: The Gold Standard

Dialectical Behavior Therapy, or DBT, is specifically designed for borderline personality disorder and is currently the only therapy with strong research evidence supporting its effectiveness for this condition. Developed by Dr. Marsha Linehan in the early 1990s, DBT was originally created to help women with BPD who were engaging in self-harm or attempting suicide.

DBT is built on two important concepts. The first is validation—the idea that your emotions are real, acceptable, and make sense given your experiences. Many people with BPD grew up in environments where their feelings were dismissed or criticized, perhaps being told they were "too sensitive" or had "no right" to feel sad or anxious. This invalidating environment, combined with emotional vulnerability, can create a painful cycle where intense feelings lead to self-criticism, which then triggers even more intense emotions.

The second concept is dialectics, a philosophy suggesting that most things in life aren't simply "black or white." DBT encourages openness to different perspectives and helps people move away from rigid, all-or-nothing thinking that can trap them in harmful patterns. For example, a DBT therapist might validate that intense sadness is real and overwhelming, but then gently challenge the belief that self-harm is the only way to cope with that sadness.

Traditional DBT includes four main components that work together. First, there's a weekly skills training group where participants learn specific techniques. Second, individuals have one-on-one therapy sessions with their own therapist. Third, there's an out-of-hours contact number patients can call when symptoms worsen between sessions. Fourth, therapists themselves meet regularly as a consultation team to support each other in providing the best care.

The skills taught in DBT fall into four categories. Mindfulness skills help people stay present in the current moment rather than being overwhelmed by past regrets or future worries. Interpersonal effectiveness skills improve communication and help maintain healthier relationships. Emotion regulation skills teach ways to manage and modify intense feelings. Finally, distress tolerance skills provide methods to survive crisis situations without making things worse through impulsive actions.

Other Forms of Talk Therapy

While DBT is the most studied approach, other types of psychotherapy can also help people with borderline personality disorder. Mental health professionals may adjust the type of therapy to best fit a person's specific needs and circumstances. All forms of talk therapy for BPD share common goals: helping people focus on their ability to function, learning to manage uncomfortable emotions, reducing impulsiveness by recognizing feelings before acting on them, and improving relationships by developing awareness of both their own feelings and others' feelings.

Therapy focuses on helping people make sense of emotionally challenging moments. The goal is to develop a clearer understanding of how thoughts, feelings, and behaviors are connected, and to find healthier ways to respond when difficult situations arise. With time and practice, many people with BPD learn to respond to triggers in less harmful ways.

The Care Programme Approach

For individuals with moderate to severe symptoms, treatment often follows a structured process called the care programme approach (CPA). This ensures that each person receives treatment tailored to their specific needs. The CPA includes four stages: first, an assessment of health and social needs; second, creation of a care plan to meet those needs; third, appointment of a care coordinator (often a social worker or nurse) who becomes the first point of contact; and fourth, regular reviews where treatment is evaluated and the care plan is updated as needed.

Treatment is typically delivered by professionals within a community mental health team (CMHT), which might include social workers, mental health nurses, pharmacists, counselors, psychotherapists, psychologists, psychiatrists, and occupational therapists. The goal is to provide day-to-day support while ensuring as much independence as possible.

The Role of Medication

While psychotherapy is the main treatment, medication may be added in certain situations. Drugs are not typically used to treat the core features of borderline personality disorder itself, but they can help manage co-occurring conditions that many people with BPD experience. These include depression, anxiety disorders, eating disorders, post-traumatic stress disorder, bipolar disorder, and substance use problems.

When medication is prescribed as part of BPD care, it serves as an adjunctive—or supporting—treatment alongside psychotherapy. The decision to add medication depends on the individual's specific symptom profile and whether they have other psychiatric conditions requiring pharmaceutical intervention.

Duration and Outcomes of Standard Treatment

Effective treatment for borderline personality disorder typically lasts more than a year. This extended timeframe allows people to truly learn and practice new skills, integrate them into daily life, and build lasting changes in how they think, feel, and behave. Over time, many people with BPD overcome their symptoms and recover. Additional treatment is recommended for those whose symptoms return after improvement.

It's important to know that many people with borderline personality disorder do get better with treatment. They can learn to live more stable and fulfilling lives, with improved relationships and better emotional control. While BPD can be serious—particularly when it involves self-harm or suicidal behavior—recovery is possible.

Emerging Approaches Being Studied in Clinical Research

Beyond the established therapies already in use, researchers continue to explore new ways to help people with borderline personality disorder. While the sources provided do not detail specific experimental drugs or novel treatment trials currently underway for BPD, the field of mental health research is active in investigating various approaches to improve outcomes for this condition.

Clinical trials for mental health conditions typically follow a structured progression. Phase I trials focus primarily on safety, testing new interventions in small groups to understand whether they cause harmful effects. Phase II trials examine efficacy, determining whether the treatment actually helps reduce symptoms or improve functioning in a larger group of participants. Phase III trials compare the new treatment directly against existing standard treatments to see if it offers advantages in terms of effectiveness, safety, or tolerability.

For borderline personality disorder specifically, research often focuses on refining existing psychotherapy techniques, understanding the brain mechanisms underlying emotional dysregulation, and developing complementary approaches that might enhance the effects of talk therapy. Some research examines how different components of therapy (such as individual sessions versus group skills training) contribute to overall improvement, helping clinicians optimize treatment delivery.

Studies also investigate how BPD treatment can be adapted for different populations and settings. For example, researchers explore whether briefer or modified versions of DBT can be effective for people who cannot commit to the full traditional program, or how treatment might be tailored for adolescents showing early signs of the disorder.

The understanding of what causes borderline personality disorder continues to evolve. Research suggests a combination of genetic factors, brain differences, and environmental experiences contribute to its development. Studies have found that certain brain areas involved in emotion regulation may function differently in people with BPD, and that brain chemicals responsible for mood regulation may not work properly. This biological understanding opens potential pathways for developing targeted interventions.

Environmental factors, particularly adverse childhood experiences such as abuse, neglect, or loss of a caregiver, appear to play a significant role in BPD development. Understanding these risk factors helps researchers design preventive interventions and trauma-informed treatments that address the roots of emotional vulnerability.

Most Common Treatment Methods

  • Dialectical Behavior Therapy (DBT)
    • Specifically designed for borderline personality disorder with strong research support
    • Includes weekly skills training groups and individual therapy sessions
    • Teaches mindfulness, interpersonal effectiveness, emotion regulation, and distress tolerance skills
    • Based on concepts of validation and dialectics to break harmful emotional cycles
    • Provides out-of-hours contact support during crisis
    • Treatment typically lasts a year or longer
    • Particularly effective for individuals with self-harm and suicidal behaviors
  • Other Forms of Psychotherapy
    • Various talk therapy approaches adjusted to meet individual needs
    • Focus on improving ability to function in daily life
    • Help manage uncomfortable emotions and reduce impulsive reactions
    • Work on improving relationships through better emotional awareness
    • Delivered by trained mental health professionals including psychiatrists, psychologists, and therapists
  • Community Mental Health Team Care
    • Coordinated treatment delivered by multidisciplinary teams
    • Includes social workers, mental health nurses, pharmacists, counselors, psychologists, and psychiatrists
    • Provides day-to-day support while promoting independence
    • Uses care programme approach for moderate to severe cases
    • Regular assessment and review of treatment progress
  • Medication as Adjunctive Treatment
    • Not primary treatment but used to address co-occurring conditions
    • May help manage depression, anxiety, or mood instability
    • Prescribed alongside psychotherapy, not as replacement
    • Tailored to individual symptom profile and additional diagnoses

Did you know?

  1. People with BPD have described it as feeling like having an "exposed nerve ending"—they're easily triggered by small things that others might barely notice, making everyday situations feel emotionally overwhelming.[3]
  2. Borderline personality disorder symptoms typically improve naturally with age—mood swings, anger, and impulsiveness often get better as people move through adulthood, even without treatment.[1]
  3. BPD is formally diagnosed only in adults, not in children or teenagers, because behaviors that look like BPD symptoms in young people often disappear naturally as they mature and develop.[8]

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Borderline personality disorder

Recruiting trials first

See all 3 trials →
Quick filters

3 clinical trials in this condition

Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Oxytocin
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ketamine Hydrochloride
  • Sponsor:Centre Hospitalier Universitaire De Toulouse
See all 3 trials →filters applied: condition = Borderline personality disorder
Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).